Présentation de l'entreprise
22nd Century Group, Inc., identified by the ticker symbol XXII, operates within the Consumer Defensive sector as a dedicated manufacturer, distributor, and seller of proprietary reduced nicotine tobacco products and very low nicotine combustible cigarettes across the United States. The company's business model focuses on contract manufacturing and the distribution of these specific tobacco variants, positioning it firmly within the Tobacco industry which is characterized by regulatory scrutiny and shifting consumer preferences regarding nicotine content. This entity employs a workforce of 32 individuals to execute its operational strategy, resulting in a total market capitalization of $1.54M and a trailing twelve-month revenue generation of $7.05M. These financial metrics collectively indicate that the company occupies a position of extreme scale limitation relative to major peers, operating as a micro-cap entity with minimal revenue throughput and a negligible presence in the broader tobacco market landscape.
Santé financière
The financial performance of 22nd Century Group, Inc. over the trailing twelve months reveals a significant operational challenge, with revenue standing at $7.05M while net income recorded a substantial loss of $-17,796,000 and EBITDA falling to $-10,504,000. The expansive gap between the $7.05M revenue figure and the $-17,796,000 net income highlights a deeply distressed cost structure where expenses, likely driven by manufacturing, regulatory compliance, or distribution logistics, vastly exceed total sales proceeds. Free cash flow for the period was $-11,770,375, indicating that the company's core operations are burning cash rather than generating liquidity, which severely constrains financial flexibility and limits the ability to fund organic growth or weather economic downturns without external capital injection. Profitability analysis shows a gross margin of -44.5%, an operating margin of -253.1%, and a profit margin of -71.7%, all of which signify that the company is losing money on every unit sold and that operational inefficiencies or high fixed costs are eroding value at an alarming rate across all levels of the income statement. Regarding liquidity and leverage, the company holds $7.15M in cash against $1.48M in debt, resulting in a debt-to-equity ratio of 7.99, a metric that suggests a highly leveraged balance sheet despite the substantial cash reserve, as the high leverage ratio implies significant financial risk relative to shareholders' equity. The current ratio stands at 2.42, which indicates that the company possesses more than twice the current assets required to cover its short-term liabilities, suggesting adequate short-term liquidity to meet immediate obligations despite the negative earnings. Finally, the return metrics show a return on equity of -116.6% and a return on assets of -29.3%, revealing that management is currently destroying shareholder value and that the asset base is generating negative returns, reflecting ineffective capital allocation in the current operational environment.
Évaluation de la valorisation
Valuation multiples for 22nd Century Group, Inc. present a complex picture due to the company's lack of profitability, with the trailing P/E ratio listed as N/A and a forward P/E of -0.14, implying that traditional earnings-based valuation methods are currently inapplicable and that future earnings expectations are deeply negative or undefined. The price-to-book ratio is calculated at 0.07, indicating that the market values the company's equity at a fraction of its book value, which often suggests that the market perceives significant intangible liabilities or operational risks that are not fully captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 0.22 and an EV/EBITDA of 0.14 further underscore the lack of earnings power, suggesting that investors are pricing the stock based on asset liquidation value or specific niche revenue streams rather than sustainable earnings potential. The stock has exhibited extreme volatility, with a 52-week high of $841.80 and a 52-week low of $1.95, meaning the current trading price sits significantly below the recent peak, reflecting a severe correction from previous market highs. The beta coefficient is recorded at 1.12, which implies that the stock's price volatility is slightly higher than the broader market, meaning that price fluctuations in XXII tend to amplify market movements rather than dampen them.
Growth & Income
The growth trajectory of the company is characterized by a contraction, with revenue growth year-over-year standing at -43.1% and earnings growth listed as N/A, indicating that the business is shrinking rapidly and that earnings are not growing faster than revenue but rather declining in tandem with the loss of sales volume. As the company does not distribute dividends, the dividend yield is N/A and the payout ratio is 0.0%, reflecting a strategy where the entity retains its meager earnings (or lack thereof) rather than distributing cash to shareholders, which is typical for companies in distress that cannot sustain regular payouts. The overall growth and income profile is defined by negative revenue expansion and zero dividend distribution, presenting a scenario where the company is actively shrinking its top line without offering any income generation to investors, thereby limiting the total return potential for holders of the XXII shares.